Advertise with us
[January 03, 2013]
Astex Pharmaceuticals to Present at Biotech Showcase 2013
DUBLIN, Calif., Jan 03, 2013 (GLOBE NEWSWIRE via COMTEX) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that James S.J. Manuso, PhD, chairman and chief executive officer, will present at Biotech Showcase 2013 on Wednesday, January 9 in San Francisco.
The Company's presentation will begin at 2:45 p.m. PT. A live webcast of the presentation will be available in the Investor Events section of the Company's website, www.astx.com. The webcast will be archived for 30 days.
About Astex Pharmaceuticals Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals developed DACOGEN(R) (decitabine) for Injection and receives significant royalties on global sales.
For more information about Astex Pharmaceuticals, Inc., please visit
The Astex Pharmaceuticals, Inc. logo is available at
pkgid=12273 CONTACT: Timothy L. Enns Astex Pharmaceuticals, Inc.
Senior Vice President Corporate Communications & Marketing Tel: +1 (925) 560-2810 E-mail: firstname.lastname@example.org Susanna Chau Astex Pharmaceuticals, Inc.
Manager Investor Relations Tel: +1 (925) 560-2845 E-mail: email@example.com Alan Roemer The Trout Group Managing Director Tel: +1 (646) 378-2945 E-mail: firstname.lastname@example.org Kari Watson MacDougall Biomedical Communications Senior Vice President Tel: +1 (781) 235-3060 E-mail: email@example.com
Back To NFVZone's Homepage